Author: healthadmin
Fast and reliable wireless connectivity is essential to everyday life. Video calling, streaming, virtual reality, and connected devices all rely on networks that are already heavily taxed. Currently, most wireless communications rely on radio-based technologies such as Wi-Fi and cellular networks. Although these systems have enabled global connectivity, they face increasing challenges such as congested radio frequencies, signal interference in crowded indoor environments, and increasing energy demands as more devices come online. One new solution is optical wireless communication, which uses light instead of radio waves to transmit data. Light can significantly expand the available bandwidth, avoid interference with existing…
Smoking cannabis directly reduced the amount of alcohol consumed by heavy drinkers during a controlled laboratory experiment. This study shows that acute marijuana intoxication can reduce the immediate urge to drink and delay the onset of alcohol intake. These findings were published in the American Journal of Psychiatry. Public health experts closely track the simultaneous use of alcohol and cannabis. With the expansion of legalization across the country, marijuana has become the most popular psychoactive substance for alcohol drinkers after tobacco. Many people practice both habits, and there is a strong overlap between those who struggle with alcohol use and…
BioNTech is turning off the lights at its Singapore factory and planned regional headquarters, which it bought from Novartis at the height of the coronavirus outbreak, reflecting a sharp reversal in the mRNA specialist’s trajectory since the end of the pandemic. After a comprehensive review, BioNTech has decided to “close our planned Singapore location by the end of February 2027,” the company confirmed to Fierce in a statement on Thursday. The move comes as the German biotech company continues to “adjust our clinical portfolio and long-term strategic direction and capabilities.” Several local publications first reported the factory closure early Thursday.…
From the majestic canyons of the Grand Canyon to the granite peaks of Yosemite National Park to the ancient trees of Alaska’s Tongass National Forest, President Donald Trump has promised to make America’s federal preserves “beautiful again.” National parks make up part of more than 600 million acres (243 million hectares) of U.S. public lands spanning forests, deserts, waterways, and wildlife refuges. “These lands include some of the most ecologically pristine and biodiverse lands in the country,” said Jenny Roland Shea, director of public lands policy at the Center for American Progress, a Washington-based think tank. But critics say these…
The UK can now officially declare that pharmaceutical exports to the US are duty-free after the UK government signed the landmark US-UK Pharmaceutical Partnership, which was first launched in December. The UK will increase the net price the NHS pays for new treatments by 25% in exchange for a tariff holiday. The deal, which will last for at least three years, will make Britain the first country in the world to impose zero percent tariffs on U.S. pharmaceutical exports, British officials said in a press release Thursday. “The partnership, first announced in December, will protect the UK’s pharmaceutical industry, which…
A medical device company spun out from Northumbria University has reached a key milestone. Receives CE Mark for an exhaled breath sampling platform that has been demonstrated in peer-reviewed studies to reliably collect saliva-free exhaled breath condensate (EBC) from deep within the lungs, making it the first technology of its kind to achieve this distinction. PulmoBioMed Ltd has been awarded the CE mark for its PBM-Hale™ platform, a non-invasive breath sampling device developed based on research carried out at Northumbria University in Newcastle. The CE-marked and US FDA-registered device is now available for deployment in clinical and research settings in…
Corti, a maker of AI-based models for healthcare, has released a new agent model for medical coding that outperforms many Big Tech models. Symphony for Medicalcoding outperforms OpenAI, Anthropic, Amazon, Oracle, and Google benchmarks by more than 25% on clinical accuracy benchmarks. The product, available via API, is built on Corti’s flagship model Symphony, which is already used by 200 teams in the US today. The company works with EHR vendors, virtual care platforms, practice management systems, and life sciences organizations around the world. Medical coding is extremely complex. The U.S. coding system, ICD-10, has approximately 70,000 diagnosis codes. Automated…
The National Comprehensive Cancer Network® (NCCN®), a coalition of leading cancer centers, announces the 2026 winners of the annual NCCN Foundation® Young Investigator Awards. This award provides early career researchers with funding to advance research on important issues in oncology. Award recipients were selected by the NCCN Oncology Research Program (ORP), which provides oversight and guidance throughout the two-year program. “NCCN is committed to providing the most effective treatment for patients with cancer,” said Dr. Crystal S. Denlinger, CEO of NCCN. “NCCN’s junior investigators will continue to serve in leadership roles within the agency and nationally. This year’s honorees have…
Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Institute (OSUCCC – James) are advancing the understanding of a promising blood test that could personalize treatment and monitoring for patients with human papillomavirus (HPV)-related throat cancer. This study JAMA Otorhinolaryngology – Head and Neck Surgeryinvestigates how circulating tumor HPV DNA (ctDNA), a blood-based test, changes before and after surgery. This study investigates how tumor biology and patient factors influence ctDNA levels. This discovery provides important new insights into how this ctDNA test can be used in conjunction with pathology reports…
With the U.S. approval of a second oral GLP-1 drug to treat obesity, analysts are starting to analyze the potential for Eli Lilly’s Foundayo to become a blockbuster hit in 2026, as well as Novo Nordisk’s similarly hot pill Wigovy, which was launched three months ahead of Lilly’s drug in January. Meanwhile, Novo, which appears intent on maintaining its first-mover advantage in the obesity drug space, has launched an aggressive defense, focusing on the company’s claims that the weight loss of oral Wigovy vs. Foundayo is “substantially greater.” With the FDA’s approval of Foundayo (orforglipron) on Wednesday, Lilly announced that…